Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Prova per aumentare la partecipazione alla FEP

1 ottobre 2026 aggiornato da: William Smith, University of Pennsylvania

Incentivi finanziari per aumentare la frequenza al trattamento nella cura della psicosi del primo episodio: uno studio pilota non randomizzato e adattivo

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.

Panoramica dello studio

Stato

Attivo, non reclutante

Tipo di studio

Interventistico

Iscrizione (Stimato)

145

Fase

  • Prima fase 1

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • North Carolina
      • Raleigh, North Carolina, Stati Uniti, 27608
        • University of North Carolina at Chapel Hill (ENCOMPASS Program)
    • Pennsylvania
      • Philadelphia, Pennsylvania, Stati Uniti, 19123
        • PEACE Program, Horizon House, Inc.
      • Philadephia, Pennsylvania, Stati Uniti, 19104
        • University of Pennsylvania

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  1. For all participants, age ≥ 18 years old.
  2. For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
  3. For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
  4. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form

Exclusion Criteria:

  1. For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
  2. For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
  3. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 8 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 8 months
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 6 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 6 months
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 4 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 4 months
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 8 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 8 months
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 6 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 6 months
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 4 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 4 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Implementation Survey Response
Lasso di tempo: Change at 8 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 8 months
Implementation Survey Response
Lasso di tempo: Change at 6 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 6 months
Implementation Survey Response
Lasso di tempo: Change at 4 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 4 months
Motivation Survey Response
Lasso di tempo: Change at 8 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 8 months
Motivation Survey Response
Lasso di tempo: Change at 6 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 6 months
Motivation Survey Response
Lasso di tempo: Change at 4 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 4 months
Ethical Concern Survey Response
Lasso di tempo: Change at 8 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 8 months
Ethical Concern Survey Response
Lasso di tempo: Change at 6 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 6 months
Ethical Concern Survey Response
Lasso di tempo: Change at 4 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 4 months

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
attrition
Lasso di tempo: Change at 8 months

rate of attrition

Change at 8 months
attrition
Lasso di tempo: Change at 6 months

rate of attrition

Change at 6 months
attrition
Lasso di tempo: Change at 4 months

rate of attrition

Change at 4 months
psychotic symptomology
Lasso di tempo: Change at 8 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Lasso di tempo: Change at 6 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Lasso di tempo: Change at 4 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 4 months
psychotic symptomology
Lasso di tempo: Change at 8 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Lasso di tempo: Change at 6 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Lasso di tempo: Change at 4 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 4 months
depression
Lasso di tempo: Change at 8 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 8 months
depression
Lasso di tempo: Change at 6 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 6 months
depression
Lasso di tempo: Change at 4 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 4 months
quality of life
Lasso di tempo: Change at 8 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 8 months
quality of life
Lasso di tempo: Change at 6 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 6 months
quality of life
Lasso di tempo: Change at 4 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 4 months
recovery
Lasso di tempo: Change at 8 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 8 months
recovery
Lasso di tempo: Change at 6 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 6 months
recovery
Lasso di tempo: Change at 4 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 4 months
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 8 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 8 months
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 6 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 6 months
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 4 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 4 months
Perceived coercion
Lasso di tempo: Change at 8 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 8 months
Perceived coercion
Lasso di tempo: Change at 6 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 6 months
Perceived coercion
Lasso di tempo: Change at 4 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 4 months
attendance rate
Lasso di tempo: Change over 8 months

number of appointments attended in a given period divided by number of appointments scheduled

Change over 8 months
attendance rate
Lasso di tempo: Change at 6 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 6 months
attendance rate
Lasso di tempo: Change at 4 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 4 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 febbraio 2025

Completamento primario (Effettivo)

18 dicembre 2025

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

20 giugno 2023

Primo inviato che soddisfa i criteri di controllo qualità

28 luglio 2023

Primo Inserito (Effettivo)

1 agosto 2023

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

6 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

1 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2023-03

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi